Activation of TGF‐beta (TGF‐β) signaling in tumor keratinocytes and the tumor microenvironment is associated with aggressive squamous cell carcinomas (SCCs), including immunosuppression and fibrosis [8, 14, 15, 16]. Here, TGFB1 is linked to neoplasm.